Matteo Lemoli

Matteo Lemoli

Auto-generated profile, based on publicly available information

Matteo Lemoli

Department of Clinical and Experimental Sciences, University of Brescia , Brescia 25123

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2024 in European Cardiology Review
Verified
Journal Article
Open access
PDF file
GBGiacomo Buso
Giacomo Buso
CRClaudia Agabiti Rosei
Claudia Agabiti Rosei
MLMatteo Lemoli
Matteo Lemoli
FCFederica Corvini
Federica Corvini
MMMaria Lorenza Muiesan
Maria Lorenza Muiesan
Resistant hypertension (RH) is defined as systolic blood pressure (SBP) or diastolic blood pressure (DBP) that remains ≥140 mmHg or ≥90 mmHg, respectively, despite an appropriate lifestyle and the use of optimal or maximally tolerated doses of a three-drug combination, including a diuretic. This definition encompasses the category of controlled RH, defined as the presence of blood pressure (BP) effectively controlled by four or more antihypertensive agents, as well as refractory hypertension, referred to as uncontrolled BP despite five or more drugs of different classes, including a diuretic. To confirm RH presence, various causes of pseudo-resistant hypertension (such as improper BP measurement techniques and poor medication adherence) and secondary hypertension must be ruled out. Inadequate BP control should be confirmed by out-of-office BP measurement. RH affects about 5% of the hypertensive population and is associated with increased cardiovascular morbidity and mortality. Once RH presence is confirmed, patient evaluation includes identification of contributing factors such as lifestyle issues or interfering drugs/substances and assessment of hypertension-mediated organ damage. Management of RH comprises lifestyle interventions and optimisation of current medication therapy. Additional drugs should be introduced sequentially if BP remains uncontrolled and renal denervation can be considered as an additional treatment option. However, achieving optimal BP control remains challenging in this setting. This review aims to provide an overview of RH, including its epidemiology, pathophysiology, diagnostic work-up, as well as the latest therapeutic developments.

31 October 2023 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
CCCarolina DE CIUCEIS
Carolina DE CIUCEIS
CRClaudia Agabiti Rosei
Claudia Agabiti Rosei
PMPaolo Malerba
Paolo Malerba
MNMatteo Nardin
Matteo Nardin
GCGiulia Chiarini
Giulia Chiarini
RDRizzoni Damiano
Rizzoni Damiano

10 February 2026 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
MLMatteo Lemoli
Matteo Lemoli
CRClaudia Agabiti Rosei
Claudia Agabiti Rosei
MMMaria Lorenza Muiesan
Maria Lorenza Muiesan

1 June 2022 in Journal Of Hypertension
Verified
Journal Article
Closed access
PMPaolo Malerba
Paolo Malerba
CRClaudia Agabiti Rosei
Claudia Agabiti Rosei
GCGiulia Chiarini
Giulia Chiarini
Matteo NardinMatteo Nardin
Matteo Nardin
APAlina Petelca
Alina Petelca
CCCarolina DE CIUCEIS
Carolina DE CIUCEIS
Objective: SARS-CoV2 infection can lead to several clinical scenarios, named COVID-19, ranging from mild manifestations to acute respiratory distress syndrome (ARDS), coagulation alterations and endothelial dysfunction. The functional impairment of the microcirculation seems play a key role in the pathophysiology and clinical consequences of COVID-19. However, to date there is no evidence of structural microvascular damage related to COVID-19. Design and method: The aim of this study is to investigate microvascular alterations by adaptive optics and vide-ocapillaroscopy in patients recently admitted for COVID-19 and re-evaluated one year later. Methods: We enrolled 153 patients admitted between February and April 2020 at the Hospital of Montichiari (Brescia) and at the Internal Medicine Department of ASST Spedali Civili - University of Brescia for respiratory failure due to SARS-CoV2-related interstitial pneumonia. Patients were evaluated two months after nalysedsation and after one year. All patients underwent a venous blood sampling for hematochemical tests, evaluation of retinal arteriolar morphology by adaptive optics, assessment of basal and total capillary density (BCD and TCD respectively) at the dorsum of the fourth finger of the non-dominant hand by videocapillaroscopy. Results: Fifty patients with completed follow-up were nalysed. An increase of internal lumen (93.8 ± 13.3 vs. 97.3 ± 14.2 micron, p < 0.001) and a reduction of wall to lumen ratio (WLR 0.30 ± 0.03 vs. 0.27 ± 0.03, p < 0.001) were observed at the follow up visit after one year (Figure). No significant differences were observed in BCD in the dorsum of the finger after one year, whereas a significant reduction in TCD was observed (p < 0.001). Microvascular changes were independent of body mass index and the presence of hypertension or diabetes mellitus. Conclusions: Preliminary data from this study show that patients with SARS-Cov2 infection present an improvement of microvascular structure after one year from the disease, such as a reduction in WLR of retinal arterioles. This suggests that COVID19 might induce structural alterations in the microcirculation which contribute to vascular damage. These changes do not seem to be influenced by the weight, presence of hypertension or diabetes.